基于智力资本的我国医药制造业绩效研究

发布时间：2018-02-14 10:11

本文关键词： 医药制造业智力资本绩效　出处：《青岛大学》2016年硕士论文　论文类型：学位论文

【摘要】：医药制造业作为高技术产业五大分类之一,在我国经济发展中具有重要地位。在医药制造业领域,我国已具备大国实力,但尖端医药技术匮乏,医药产品附加值低,医药制造业综合绩效不高和区域发展不均衡已是我国医药制造业发展的现实问题。当前我国医药制造业发展面临的紧迫问题是:应如何依据医药制造业绩效发展目标确定要素投入区域?依据绩效目标的不同,各项要素的投入在不同区域又有怎样的优先顺序?针对上述问题的存在,本文通过对我国26个省、市1998-2013年智力资本与其绩效的考察,从智力资本三要素视角展开了对以医药制造业智力资本与其绩效为研究对象,量化二者的研究,并尝试从智力资本角度找出解决上述问题的对策。本文有关医药制造业研究的主要结论如下:1.医药制造业智力资本三要素的人力资本、关系资本和更新资本均正向影响其经营绩效和创新绩效。2.简单模型回归分析结果显示:关系资本对经营绩效的贡献程度最大,人力资本对创新绩效的贡献程度最大。3.调节变量的加入影响医药制造业智力资本要素对其绩效的贡献程度。本文的创新点有:(1)研究视角的创新,将三维度智力资本与医药制造业发展相结合来进行考察研究,旨在解决智力资本在医药制造业区域发展中的优先投入区域和优先投入要素问题;(2)量化维度的创新,借鉴已有研究在结构洞理论对人际和社会关系的研究基础上,在医药制造业理论依据方面引入了结构洞理论,以更好的解释量化智力资本中关系资本对医药制造业绩效的影响;(3)影响机制的创新,在单一变量考察的基础上,加入了智力资本维度因素相结合的调节变量考察,对智力资本影响下的医药制造业绩效有了新的认识。
[Abstract]:Pharmaceutical industry is one of the five major categories of high-tech industry, plays an important role in the economic development of our country. In the pharmaceutical manufacturing industry, our country has great strength, but lack of advanced medical technology, medical products with low added value, the comprehensive performance of the pharmaceutical industry is not high and the regional development imbalance is a reality problem China's pharmaceutical industry development. The urgent problems in development of Chinese pharmaceutical industry is facing: how should according to the goal of the development of pharmaceutical industry performance determine the input area? Based on the performance of different goals, the inputs and how the priority in different regions? In view of the above problems, this article through to the 26 provinces in China, study 1998-2013 years of intellectual capital and the performance of the three elements of intellectual capital, from the perspective of the pharmaceutical manufacturing industry of intellectual capital and its performance as research object, quantitative two The study, and try to find out the countermeasures to solve these problems from the perspective of intellectual capital. In this paper, the main conclusions about the research of medicine manufacturing pharmaceutical manufacturing industry are as follows: 1. the three elements of intellectual capital human capital, relationship capital and renewal capital have positive effect on the operating performance and innovation performance of simple.2. model regression analysis showed that the contribution of the relationship between the extent of capital on business performance, human capital contribution to the innovation performance of maximum.3. adjustment variables influence the pharmaceutical manufacturing industry of intellectual capital on the performance of the contribution degree. The creative points of this paper are: (1) the innovation of research perspective, the development of three-dimensional intellectual capital and the combination of the pharmaceutical manufacturing industry to study, to solve the intellectual capital in the pharmaceutical manufacturing industry give priority to investment in regional development and regional priority inputs; (2) the quantitative dimensions of innovation, reference The existing research on the structural holes theory basic research on interpersonal and social relations, in the pharmaceutical manufacturing industry theory is introduced to explain the relationship between the structural hole theory, quantization of intellectual capital better capital impact on the pharmaceutical manufacturing industry performance; (3) innovation mechanism, based on a single variable, add the dimension of intellectual capital factors combined with variable investigation, a new understanding of the performance of pharmaceutical manufacturing industry under the influence of intellectual capital.

【学位授予单位】：青岛大学
【学位级别】：硕士
【学位授予年份】：2016
【分类号】：F426.72;F272.92

【相似文献】